Login to Your Account



FDA Submissions, Approvals & Other Actions: October 2011


Monday, November 14, 2011

Company (Location)

Product

Description

Indication

Status (Date)#


AUTOIMMUNE

Genzyme Corp. (Cambridge, Mass.) and Sanofi-Aventis SA (Paris)

Teriflunomide

Oral immunosuppressant

Multiple sclerosis

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription